KLHL11: A Potential Drug Target Or Biomarker for Diseases (G55175)

Target Name: KLHL11

NCBI ID: G55175

KLHL11

Other Name(s): Kelch-like protein 11 | kelch like family member 11 | Kelch like family member 11 | KLH11_HUMAN

KLHL11: A Potential Drug Target Or Biomarker for Diseases

Kelch-like protein 11 (KLHL11) is a protein that is expressed in various tissues throughout the body, including the brain, heart, lungs, and intestines. It is a member of the Kelch-like protein family, which includes several similar proteins that are involved in various cellular processes, including cytoskeletal organization, cell signaling, and inflammation.

Recent studies have identified KLHL11 as a potential drug target or biomarker for several diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because KLHL11 has been shown to play a role in the development and progression of these conditions, and may be involved in the regulation of important cellular processes that contribute to their development.

One of the key functions of KLHL11 is its role in the regulation of cytoskeletal organization. In various cell types, KLHL11 is involved in the formation of the actin filament, which is a structure that is essential for cell movement and the maintenance of cell shape. This is important for many cellular processes, including cell signaling, which is critical for the regulation of many cellular processes that are essential for life.

In addition to its role in cytoskeletal organization, KLHL11 has also been shown to be involved in the regulation of cell signaling. Many proteins that are involved in cell signaling, including tyrosine kinases, phosphatidylinositol (PI) kinases, and G protein-coupled receptors, are located in the cytoplasm of cells, and are involved in the regulation of various cellular processes. KLHL11 has been shown to be involved in the regulation of the activity of these proteins, and may be a potential drug target or biomarker for diseases that are characterized by the over-expression or dysfunction of these proteins.

Another function of KLHL11 is its role in the regulation of inflammation. Many diseases, including cancer, are characterized by the activation and proliferation of immune cells, which can contribute to the development and progression of these diseases. KLHL11 has been shown to be involved in the regulation of the activation and function of immune cells, and may be a potential drug target or biomarker for these diseases.

In conclusion, KLHL11 is a protein that is involved in various cellular processes that are essential for the development and progression of many diseases. As a potential drug target or biomarker, KLHL11 may be a valuable tool for the development of new treatments for a variety of diseases. Further research is needed to fully understand the role of KLHL11 in these diseases, and to develop effective treatments based on this protein.

Protein Name: Kelch Like Family Member 11

Functions: Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates the ubiquitination of target proteins, leading most often to their proteasomal degradation

The "KLHL11 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about KLHL11 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets